Guardian Pharmacy Services, Inc. (NYSE:GRDN) Receives $41.33 Consensus Target Price from Brokerages

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have been given an average rating of “Moderate Buy” by the nine ratings firms that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $41.3333.

Several analysts have issued reports on GRDN shares. Bank of America started coverage on Guardian Pharmacy Services in a report on Monday, April 27th. They set a “buy” rating and a $42.00 price target for the company. Zacks Research lowered Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. UBS Group reissued a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Oppenheimer boosted their price target on Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th.

Guardian Pharmacy Services Price Performance

Shares of GRDN opened at $38.51 on Tuesday. Guardian Pharmacy Services has a one year low of $19.17 and a one year high of $41.36. The firm has a market capitalization of $1.92 billion, a P/E ratio of 46.39, a PEG ratio of 2.52 and a beta of 0.09. The business has a fifty day moving average of $36.85 and a 200 day moving average of $33.00.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.24 by $0.05. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The company had revenue of $336.60 million during the quarter, compared to analyst estimates of $329.89 million. During the same quarter in the previous year, the company posted $0.22 earnings per share. Guardian Pharmacy Services’s revenue was up 2.2% compared to the same quarter last year. Analysts expect that Guardian Pharmacy Services will post 1.18 EPS for the current fiscal year.

Insider Buying and Selling at Guardian Pharmacy Services

In other news, insider David K. Morris sold 187,855 shares of the company’s stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $29.68, for a total value of $5,575,536.40. Following the completion of the transaction, the insider owned 254,472 shares of the company’s stock, valued at $7,552,728.96. This represents a 42.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Kendall Forbes sold 346,672 shares of the company’s stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $29.68, for a total value of $10,289,224.96. Following the completion of the transaction, the insider directly owned 453,256 shares of the company’s stock, valued at approximately $13,452,638.08. This trade represents a 43.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 9,726,405 shares of company stock valued at $288,679,700 in the last ninety days. 32.96% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Guardian Pharmacy Services

Hedge funds have recently made changes to their positions in the business. Ameritas Investment Partners Inc. lifted its position in shares of Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after buying an additional 345 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Guardian Pharmacy Services by 3.4% in the fourth quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock worth $541,000 after buying an additional 593 shares in the last quarter. Police & Firemen s Retirement System of New Jersey lifted its position in shares of Guardian Pharmacy Services by 20.4% in the fourth quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock worth $183,000 after buying an additional 1,028 shares in the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of Guardian Pharmacy Services in the third quarter worth about $30,000. Finally, Parkside Financial Bank & Trust lifted its position in shares of Guardian Pharmacy Services by 70.5% in the third quarter. Parkside Financial Bank & Trust now owns 3,248 shares of the company’s stock worth $85,000 after buying an additional 1,343 shares in the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.